Atossa Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.11

-0.15 (-2.85%)

As of Apr 1, 10:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +64.8% upside

Low Target $5.85

Average Target $8.42

High Target $9.99

Current Price $5.11

Current
$5.11

Target
$8.42

$5.85 $8.42 avg $9.99

Scenario Analysis

Bear Case

$5.85

14.5%

Low target

Base Case

$8.42

+64.8%

Avg target

Bull Case

$9.99

+95.5%

High target

Risk/Reward

6.6x

Highly favorable

Price in Context

52-Week High

$19.35

-73.6% from high

52-Week Low

$3.76

+35.9% from low

Target vs 52W High

$8.42

-56.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%